Cross, Troy J.

The equal pressure point (EPP) states that expiratory flow limitation occurs at the precise location along the tracheobronchial tree where intraluminal and peribronchial pressures are equal (i.e., where the local transmural pressure is 0 cmH 2 O). The EPP may be determined numerically via the expiratory isovolume pressure flow (IVPF) curve. For instance, using data from a given isovolume curve, the EPP is determined as the point along the x‐axis at which pressure‐flow data fails to conform to Rohrer’s equation: driving pressure = k 1 (flow) + k 2 (flow 2 ). The probability of incurring expiratory flow‐limitation can be greatly determined by the EPP such that a lower EPP at a given lung volume requires only minimal pressure development to create a flow‐limiting segment during expiration. The EPP is affected by two principal factors: lung elastic recoil (P LUNG ) & airway geometry. Given recent evidence suggesting that airway geometry is different between men & women, we sought to determine whether the EPP is likewise affected by sex in healthy adults. Purpose Determine whether or not there is an effect of sex on the magnitude of the EPP. Methods To address this question, 11 men (23.1 ± 4.8 years) and 12 women (21.2 ± 1.0 years) completed a study requiring two visits to the laboratory. On the initial visit, we obtained written informed consent and conducted spirometry to ensure subjects met the inclusion criteria of normal (>85% of predicted) lung function. During the second visit, a balloon catheter was passed intranasally to the lower one‐third of the esophagus and remained there for the duration of the visit to measure esophageal pressure (P ES ). Subjects then performed a minimum of 10–15 graded vital capacity maneuvers from 100‐5% of maximal effort. Data were imported into Matlab and, using custom‐written code, multiple calculations were performed. First, the lowest effort vital capacity efforts were taken as quasi‐static expiratory deflations of the lung and the negative sign of P ES was taken to equal P LUNG . Second, alveolar pressure (P ALV ) was taken to equal P ES + P LUNG . Finally, the EPP was determined by iteratively fitting Rohrer’s equation to pressure‐flow data at a given iso‐volume. The pressure at which Rohrer’s equation no longer adequately fit the data (>5% error) was termed the EPP. To test for an effect of sex and lung volume, a two‐way ANOVA was computed. Pairwise comparisons were adjusted for multiple comparisons using the Tukey‐Sidak post hoc test. Results There was no effect of sex on P LUNG , but P ALV was greater in men than women throughout the entire VC range. EPP was significantly greater in men than women during the initial half of VC (95‐55% of VC) (p < 0.05), but not the remaining half (p > 0.05). Conclusion Because P LUNG did not differ between men and women, the differing location of EPP was the result of a greater P ES in men. This suggests that the larger airways present in men are more resistant to compression than those of women.

The respiratory muscle pressure (P mus ) waveform lends insight into the patterns of net inspiratory v expiratory muscle recruitment under a wide variety of conditions, including mechanical ventilation, spontaneous breathing, and during exercise. On this last point, inspection of the P mus waveform during incremental and constant work rate cycling reveals that inspiratory and expiratory muscle recruitment systematically increase with rising minute ventilations, and that the duration of post‐inspiratory inspiratory activity (PIIA) gradually disappears from low to high levels of respiratory motor output. In recent years, it has become increasingly evident that the work of breathing is systematically higher for women compared with men at a given minute ventilation during exercise. Yet, no study has examined the potential sex differences in the evolution of P mus (and its components; e.g., PIIA) during exercise. Thus, a comprehensive assessment of the P mus waveform during exercise between sexes is warranted. Purpose To compare the evolution of inspiratory and expiratory P mus between men and women during incremental cycling. Methods Thirteen men (21 ± yrs; 181 ± 5 cm; 82 ± 11 kg) and 10 women (21 ± 1 yrs; 165 ± 6 cm; 62 ± 6 kg) visited the laboratory on two separate occasions. The first occasion was used to obtain informed consent and to screen participants for normal pulmonary function (>85% age‐predicted). On the second visit, participants were instrumented with an esophageal balloon catheter to estimate variations in pleural pressure (P pl ). Quasi‐static relaxation curves were obtained to measure chest wall recoil pressure (P cw ). Participants then completed an incremental cycling protocol until volitional exhaustion. P mus was calculated at given minute ventilations during the exercise protocol as follows: P mus = P cw – P pl . Results The peak inspiratory P mus were significantly greater in females compared with men at a given minute ventilation during incremental cycling ( P < 0.05), yet peak expiratory P mus was similar between sexes. The average rates of change (slope) in P mus during inspiration & expiration were significantly faster in females than males at a given minute ventilation ( P < 0.05). Finally, the duration of PIIA (expressed as a fraction of expiratory time) gradually decreased with increasing minute ventilation during exercise ( P < 0.05). This reduction in PIIA was however similar between men and women. Conclusion The primary finding of this study was that the pattern of respiratory muscle recruitment was different between sexes during incremental cycling, insofar as women displayed systematically larger inspiratory P mus , and faster rates of net inspiratory & expiratory pressure‐development compared with men at matched ventilations. However, no differences in PIIA between sexes were observed. Support or Funding Information This research was funded by preliminary data funds provided by Northern Arizona University (JWD). TJC was supported by the Irene Diamond Fund/American Federation for Aging Research Postdoctoral Transition Award during the time of this study.

Background Previous studies have demonstrated that the near‐infrared spectroscopy venous occlusion technique (NIRS‐VOT) provides a valid assessment of regional forearm muscle blood flow; however, day‐to‐day reproducibility of hemodynamic variables derived from the NIRS‐VOT remains to be determined, particularly across the range of physiological blood flows observed during handgrip exercise. Purpose The purpose of this study was to evaluate the day‐to‐day reproducibility of forearm hemodynamics assessed via the NIRS‐VOT. Methods Near‐infrared spectroscopy (NIRS) data were obtained from the flexor digitorum superficialis muscle on the right arm of 14 young, healthy adults (age: 27 ± 6 yrs; BMI: 24.6 ± 2.8 kg·m −2 ). The NIRS‐VOT was performed via rapid inflation of a pneumatic cuff placed on the upper arm for approximately 10 s. The NIRS‐VOT was performed at rest, and immediately after a 15 s isometric handgrip contraction at 20%, 40% and 60% of the subject’s maximum voluntary contraction. Measurements were repeated 3–5 times. Participants returned to the laboratory for a second visit on a separate day, and repeated the same number of measurements. Forearm blood flow (FBF), and blood pressure were measured on a beat‐by‐beat basis, and forearm vascular conductance (FVC) was calculated. FBF and FVC were subsequently compared for day‐to‐day reproducibility. Results FBF and FVC significantly increased with the intensity of handgrip exercise ( P < 0.05); however, these measures of forearm hemodynamics were not significantly different ( P >0.05) between Day 1 and Day 2 at each exercise‐intensity (Table ). Conclusion The findings of the present study indicate that the NIRS‐VOT provides a reliable assessment of regional forearm muscle hemodynamics across a physiological range of blood flows incurred by isometric handgrip exercise. Support or Funding Information MJJ is funded by the NIH (R‐35‐HL139854) and the Mayo Foundation. CCW is supported by the NIH training grant (5T32DK007352‐39), JRS is supported by AHA (18POST3990251), and TJC is funded by AFAR Postdoctoral Transition Award (DIAMOND18161). FBF and FVC on experimental days Day 1 Day 2 P ‐value FBF , mL · min − 1 · 100mL − 1 (tissue) Rest 2.0 ± 0.5 0.8 ± 0.2 0.001 20% MVC 14.4 ± 2.65 15.4 ± 2.4 0.679 40% MVC 26.0 ± 5.19 28.0 ± 4.3 0.606 60% MVC 39.4 ± 6.39 47.4 ± 7.7 0.858 FVC , mL · min − 1 · 100 mmHg − 1 Rest 170 ± 47.3 72 ± 16.4 0.001 20% MVC 1297 ± 227.8 1454 ± 209.6 0.380 40% MVC 2496 ± 492.8 2656 ± 434.0 0.912 60% MVC 3820 ± 659.1 4542 ± 744.7 0.535 MVC , kg 49.4 ± 3.0 47.9 ± 2.6 0.721 Abbreviations: FBF, forearm blood flow; FVC, forearm vascular conductance; MVC, maximal voluntary contraction. Values are presented as means ± SE. P values indicate comparison between days 1 and 2.

Heart failure (HF) is a complex and multifaceted disease. The disease affects multiple organ systems, including the respiratory system. This review provides three unique examples illustrating how the cardiovascular and respiratory systems interrelate because of the pathology of HF. Specifically, these examples outline the impact of HF pathophysiology on 1) respiratory mechanics and the mechanical “cost” of breathing; 2) mechanical interactions of the heart and lungs; and on 3) abnormalities of pulmonary gas exchange during exercise, and how this may be applied to treatment. The goal of this review is to, therefore, raise the awareness that HF, though primarily a disease of the heart, is accompanied by marked pathology of the respiratory system.

The purpose of this report was to 1) detail the construction of a low-cost device that provides a “reference” flow waveform for pneumotachograph (PNT) calibration, i.e., the “syringe potentiometer” (SP), and to compare the 2) accuracy and 3) practical performance of “calibration curves” obtained with the SP device to other more established methods of PNT calibration, i.e., the weighted averaging (WA) and polynomial least-squares (PolyLS) methods. Volume and flow waveforms obtained via the SP device were validated against a motion capture system and were deemed accurate surrogates of actual syringe volume and flows. The SP device was used to construct a calibration curve of a PNT by dividing the flow waveform of the SP by the analog output of the PNT amplifier. A total of 187 inspiratory and 187 expiratory strokes were collected. When the entire data set of expiratory strokes was used, the SP, WA, and PolyLS methods together demonstrated acceptable volume and flow errors as per American Thoracic Society/European Respiratory Society recommendations (less than ±3.5% and less than ±5.0% errors, respectively). The “practical” performance of each method was assessed with a nested subsampling procedure, whereby volume and flow errors were evaluated as the number of strokes was increased (in blocks of 5 strokes). To this end, the SP method demonstrated practical performance superior to that of the WA and PolyLS approaches, whereby acceptable volume and flow errors were achieved after only 5 calibration strokes; the WA and PolyLS methods required 15 and 20 strokes, respectively, to achieve the same level of volume and flow accuracy.NEW & NOTEWORTHY This report describes the construction and validation of a low-cost device for the purposes of pneumotachograph (PNT) calibration: the “syringe potentiometer” (SP). Calibration of a PNT with the SP device yielded acceptable volume and flow errors (<3.5% and 5%, respectively) across a wide range of flows (<0.5 to 15 L/s). The SP device offered superior “practical performance” over other established PNT calibration methods, whereby acceptable volume and flow errors were achieved after only five calibration strokes.

We propose that abnormalities of the pulmonary system contribute significantly to the exertional dyspnea and exercise intolerance observed in patients with chronic heart failure. Interventions designed to address the deleterious pulmonary manifestations of heart failure may, therefore, yield promising improvements in exercise tolerance in this population.

Introduction: Long-term use of continuous-flow left ventricular assist devices may have negative consequences for autonomic, cardiovascular and gastrointestinal function. It has thus been suggested that non-invasive monitoring of arterial pulsatility in patients with a left ventricular assist device is highly important for ensuring patient safety and longevity. We have developed a novel, semi-automated frequency-domain-based index of arterial pulsatility that is obtained during suprasystolic occlusions of the upper arm: the ‘cuff pulsatility index’. Purpose: The purpose of this study was to evaluate the relationship between the cuff pulsatility index and invasively determined arterial pulsatility in patients with a left ventricular assist device. Methods: Twenty-three patients with a left ventricular assist device with end-stage heart failure (six females: age = 65 ± 9 years; body mass index = 30.5 ± 3.7 kg m −2 ) were recruited for this study. Suprasystolic occlusions were performed on the upper arm of the patient’s dominant side, from which the cuff pressure waveform was obtained. Arterial blood pressure was obtained from the radial artery on the contralateral arm. Measurements were obtained in triplicate. The relationship between the cuff pressure and arterial blood pressure waveforms was assessed in the frequency-domain using coherence analysis. A mixed-effects approach was used to assess the relationship between cuff pulsatility index and invasively determined arterial pulsatility (i.e. pulse pressure). Results: The cuff pressure and arterial blood pressure waveforms demonstrated a high coherence up to the fifth harmonic of the cardiac frequency (heart rate). The cuff pulsatility index accurately tracked changes in arterial pulse pressure within a given patient across repeated measurements. Conclusions: The cuff pulsatility index shows promise as a non-invasive index for monitoring residual arterial pulsatility in patients with a left ventricular assist device across time.

Airway luminal area is the major determinant of resistance to airflow in the tracheobronchial tree. Women may have smaller central conducting airways than men; however, previous evidence is confounded by an indirect assessment of airway geometry and by subjects with prior smoking history. The purpose of this study was to examine the effect of sex on airway size in healthy nonsmokers. Using low-dose high-resolution computed tomography, we retrospectively assessed airway luminal area in healthy men ( n = 51) and women ( n = 73) of varying ages (19–86 yr). Subjects with a positive smoking history, cardiopulmonary disease, or a body mass index > 40 kg/m2 were excluded. Luminal areas of the trachea, right and left main bronchus, bronchus intermediate, left and right upper lobes, and the left lower lobe were analyzed at three discrete points. The luminal areas of the conducting airways were ~26%–35% smaller in women. The trachea had the largest differences in luminal area between men and women (298 ± 47 vs. 195 ± 28 mm2 or 35% smaller for men and women, respectively), whereas the left lower lobe had the smallest differences (57 ± 15 vs. 42 ± 9 mm2 or 26% smaller for men and women, respectively). When a subset of subjects was matched for height, the sex differences in airway luminal area persisted, with women being ~20%–30% smaller. With all subjects, there were modest relationships between height and airway luminal area ( r = 0.73–0.53, P < 0.05). Although there was considerable overlap between sexes, the luminal areas of the large conducting airways were smaller in healthy women than in men. NEW & NOTEWORTHY Previous evidence for sex differences in airway size has been confounded by indirect measures and/or cohorts with significant smoking histories or pathologies. We found that central airways in healthy women were significantly smaller (~26%–35%) than men. The significant sex-difference in airway size was attenuated (20%–30% smaller) but preserved in a subset of subjects matched for height. Over a range of ages, healthy women have smaller central airways than men.